Everyday ScienceNovel theranostic agent targets multiple cancer types Posted on July 2, 2023September 15, 2023 by bricemarsters0 comments on “Novel theranostic agent targets multiple cancer types” Continue reading "Novel theranostic agent targets multiple cancer types"
Everyday ScienceTypes of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer Posted on May 31, 2023September 24, 2023 by bricemarsters0 comments on “Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer” Continue reading "Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer"
Everyday ScienceBreast cancer tumors disrupt the immune system remotely favoring their own growth Posted on May 9, 2023May 9, 2023 by bricemarsters0 comments on “Breast cancer tumors disrupt the immune system remotely favoring their own growth” Continue reading "Breast cancer tumors disrupt the immune system remotely favoring their own growth"
Everyday ScienceChemotherapy drug reaches brain in humans for first time Posted on May 6, 2023May 5, 2023 by bricemarsters0 comments on “Chemotherapy drug reaches brain in humans for first time” Continue reading "Chemotherapy drug reaches brain in humans for first time"
Everyday ScienceImplantable device shrinks pancreatic tumors Posted on April 18, 2023April 18, 2023 by bricemarsters0 comments on “Implantable device shrinks pancreatic tumors” Continue reading "Implantable device shrinks pancreatic tumors"
Everyday ScienceNew therapy harnesses patients’ blood cells to fight tumors Posted on April 15, 2023April 12, 2023 by bricemarsters0 comments on “New therapy harnesses patients’ blood cells to fight tumors” Continue reading "New therapy harnesses patients’ blood cells to fight tumors"
Everyday ScienceIdentifying cancer genes’ multiple personalities Posted on April 13, 2023April 12, 2023 by bricemarsters0 comments on “Identifying cancer genes’ multiple personalities” Continue reading "Identifying cancer genes’ multiple personalities"
Everyday ScienceIndustry Matters: From Elite Responders to M2 macrophages – OncoResponse’s approach to cancer immunotherapy. Posted on August 31, 2022January 4, 2023 by scientificinquirer0 comments on “Industry Matters: From Elite Responders to M2 macrophages – OncoResponse’s approach to cancer immunotherapy.” Continue reading "Industry Matters: From Elite Responders to M2 macrophages – OncoResponse’s approach to cancer immunotherapy."
Everyday ScienceBest way to kill a tumor? Starve it to death Posted on July 18, 2018July 18, 2018 by scientificinquirer1 comment on “Best way to kill a tumor? Starve it to death” Continue reading "Best way to kill a tumor? Starve it to death"
Everyday ScienceNew neoantigen therapy is a step closer to personalized cancer treatment Posted on July 8, 2017July 7, 2017 by scientificinquirer0 comments on “New neoantigen therapy is a step closer to personalized cancer treatment” Continue reading "New neoantigen therapy is a step closer to personalized cancer treatment"